Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Go back to Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation| AbbVie (NYSE: ABBV) | Delayed: 262.90 -2.89 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $265.79 | 52 Week High | $68.12 | |||
| Open | $264.60 | 52 Week Low | $50.71 | |||
| Day High | $265.00 | P/E | 57.03 | |||
| Day Low | $260.31 | EPS | $4.61 | |||
| Volume | 3,308,604 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.07 +0.30 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.77 | 52 Week High | $333.65 | |||
| Open | $219.34 | 52 Week Low | $223.02 | |||
| Day High | $222.00 | P/E | 28.31 | |||
| Day Low | $218.69 | EPS | $7.81 | |||
| Volume | 647,213 | |||||
